BioCentury
ARTICLE | Distillery Therapeutics

Modulating RNA splicing through RBM39 and PRMT inhibition to induce tumor neoantigen expression

July 1, 2021 11:34 PM UTC

DISEASE CATEGORY: Cancer

INDICATION: Colorectal cancer; melanoma...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article